Newsletter/Booklets 7th Jul 2023

Market Access Barriers in The Pharmaceutical Sector in India’s Key Export Destinations

Authors

Parthsarathi JhaPartner | New Delhi | Noida
Sanjay NotaniPartner | Mumbai
Mitul KaushalConsultant | Delhi NCR
Harika BakarajuPrincipal Associate | Mumbai
Naghm GheiPrincipal Associate | Delhi NCR
Divyashree SuriSenior Associate | Delhi NCR

Latest Thought Leadership

Alerts & Updates 20th Feb 2026

Unified Registration and Master Key for Capital Market Intermediaries in GIFT-IFSC

Read More
Alerts & Updates 20th Feb 2026

RBI issues new framework for bank credit facilities to capital market intermediaries

Read More
Alerts & Updates 19th Feb 2026

IFSCA Issues a Framework to facilitate Co-investment by Venture Capital Schemes and Restricted Schemes

Read More
Alerts & Updates 16th Feb 2026

Sanctions and Export Controls Update: U.S. Sanctions and Export Controls – Heightened Enforcement

Read More

This report examines the regulatory environment of some of India’s key trading partners, with a view to identify existing and potential trade barriers in exporting pharmaceuticals in these markets.  This serves as a ready reckoner and comprehensive guide for the pharmaceutical industry.

Click here

Privacy Policy

As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.